Abstract
There is intense interest in the identification of novel biomarkers which improve the diagnosis of heart failure. Serum samples from 52 patients with systolic heart failure (EF<40% plus signs and symptoms of failure) and 57 controls were analyzed by gas chromatography - time of flight - mass spectrometry and the raw data reduced to 272 statistically robust metabolite peaks. 38 peaks showed a significant difference between case and control (p
Original language | English |
---|---|
Pages (from-to) | 413-426 |
Number of pages | 14 |
Journal | Metabolomics |
Volume | 3 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Dec 2007 |